Neomorph Announces First Patient Dosed in Phase 1/2 Trial Evaluating NEO-811 For the Treatment of Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Initiation of trial marks first-in-human milestone for Neomorph’s novel molecular glue degrader…
NEXEN TIRE Strengthens Global Market Penetration with Locally Customized Products
Launching ultra-high-performance (UHP) N’FERA Sport in U.S. and strengthening distribution competitiveness through…
Celebrating India’s Retail Heroes with Coca-Cola’s ‘Locally Yours’ Campaign
NEW DELHI, Sept. 1, 2025 /PRNewswire/ -- The first to open, the…
